She taught me that living with cancer doesn't mean living without beauty,' said the honoree at the nonprofit's 20th ...

Kirsten Bryant, a pancreatic cancer researcher at UNC Chapel Hill, points to cancerous cell samples that have been dosed at ...

Pfizer and Arvinas' experimental treatment significantly extends progression-free survival in breast cancer patients with ...

A large study conducted in California highlights that exposure to wildfire smoke elevates the mortality risk among non-small ...

Fecal immunochemical testing (FIT) was more accurate than blood-based testing for detecting advanced precancerous colorectal ...

Mirele Savegnago Mialich Grecco, a nutritionist and one of the study’s authors, explained that breast cancer patients often ...

Dr. M. Blair Marshall, thoracic oncology surgeon with the Jellison Cancer Institute, was the first physician on the Gulf Coast to use the technology ...

The new AI test, built by a team from the US, UK and Switzerland, shows which men would most likely benefit from abiraterone.

Palliative nurse's notes, Aug. 2, 2019: "Participated in Hospice meeting with patient. Seth (spouse), mother, father, bedside RN. Andrea from Hospice was on speakerphone. Discussed philosophy of ...

A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending ...

An AI test boosts cure chances for prostate cancer by predicting who benefits from abiraterone, reducing side effects and ...

“The AI test has a negligible failure rate, while current genomic tests have a failure rate of 20% to 30%, necessitating ...